ES
Enavate Sciences Portfolio holdings
AUM
$177M
1 Year Est. Return
–
AUM
$133M
AUM Growth
-$6.52M
(-4.7%)
Holding
6
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Immunome
IMNM
$1.4B
| $32.1M | 24.18% |
4,768,583
+1,290,322
|
|
||
|
ZBIO
2
Zenas BioPharma
ZBIO
$1.47B
| $29.7M | 22.39% |
3,761,359
|
|
||
|
SION
3
Sionna Therapeutics
SION
$1.69B
| $25.9M | 19.53% |
+2,478,030
|
|
||
4
CAMP4 Therapeutics
CAMP
$83.9M
| $15.1M | 11.41% |
3,785,802
|
|
||
|
UPB
5
Upstream Bio Inc
UPB
$1.39B
| $15.1M | 11.34% |
2,459,703
|
|
||
6
Compass Therapeutics
CMPX
$642M
| $14.8M | 11.15% |
7,788,150
|
|